Themis Medicare Technical Momentum Shifts Amid Market Challenges

Nov 26 2025 08:03 AM IST
share
Share Via
Themis Medicare, a key player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its technical momentum, reflecting a complex interplay of bearish and bullish signals across multiple timeframes. Recent market data reveals a nuanced picture of price action and indicator behaviour, underscoring the challenges faced by the stock amid broader market dynamics.



Technical Trend Overview


The technical trend for Themis Medicare has transitioned from mildly bearish to a more pronounced bearish stance. This shift is evident in several key indicators that investors and analysts closely monitor to gauge momentum and potential price direction. The daily moving averages currently signal a bearish trend, suggesting that short-term price action is under pressure. Meanwhile, weekly and monthly indicators present a mixed landscape, with some oscillators hinting at underlying strength despite prevailing downward momentum.



MACD Signals Across Timeframes


The Moving Average Convergence Divergence (MACD) indicator offers a divergent view depending on the timeframe considered. On a weekly basis, the MACD remains mildly bullish, indicating some positive momentum in the intermediate term. However, the monthly MACD reflects a bearish posture, signalling that longer-term momentum is subdued. This divergence between weekly and monthly MACD readings suggests that while short- to medium-term price movements may find intermittent support, the overarching trend remains challenged.



RSI and Momentum Indicators


The Relative Strength Index (RSI) for Themis Medicare does not currently provide a definitive signal on either the weekly or monthly charts. This absence of a clear RSI indication points to a lack of strong momentum in either direction, implying that the stock is neither overbought nor oversold at these intervals. Complementing this, the Know Sure Thing (KST) indicator shows a bullish signal on the weekly chart but turns bearish on the monthly scale, reinforcing the theme of conflicting momentum signals across different time horizons.




Transformation in full progress! This Micro Cap from Auto Ancillary just achieved sustainable profitability after tough times. Be early to witness this powerful comeback story!



  • - Sustainable profitability reached

  • - Post-turnaround strength

  • - Comeback story unfolding


Be Early to the Comeback →




Bollinger Bands and Price Volatility


Bollinger Bands on both weekly and monthly charts indicate a bearish stance, suggesting that price volatility is skewed towards the downside. This technical parameter often reflects increased selling pressure or a contraction in price range with a downward bias. The daily price action supports this view, with Themis Medicare’s current price at ₹103.05, slightly below the previous close of ₹103.80. The stock’s intraday range today has fluctuated between ₹102.00 and ₹106.60, indicating some volatility but within a relatively narrow band compared to its 52-week high of ₹309.65 and low of ₹98.00.



Volume and Dow Theory Insights


On-Balance Volume (OBV) analysis shows a mildly bearish trend on the weekly chart, while the monthly OBV does not indicate a clear trend. This suggests that volume flow is not strongly supporting upward price movement, which can be a cautionary sign for momentum traders. Dow Theory assessments add further nuance, with weekly readings mildly bearish and monthly readings mildly bullish. This divergence highlights the complexity of the stock’s price action and the need for investors to consider multiple timeframes when analysing momentum.



Comparative Returns and Market Context


Examining Themis Medicare’s returns relative to the Sensex provides additional context for its technical momentum. Over the past week, the stock’s return stands at -9.72%, contrasting sharply with the Sensex’s marginal decline of -0.10%. The one-month return for Themis Medicare is -18.34%, while the Sensex has recorded a positive 0.45% return. Year-to-date figures reveal a significant divergence, with Themis Medicare at -60.84% against the Sensex’s 8.25%. Over the one-year horizon, the stock’s return is -65.26%, compared to the Sensex’s 5.59%. Longer-term returns over three, five, and ten years show positive gains for Themis Medicare, though these remain below the Sensex’s respective benchmarks.



Price Levels and Market Capitalisation


Themis Medicare’s current market capitalisation is graded modestly within its sector, reflecting its small-cap status. The stock’s price has been under pressure, trading near its 52-week low of ₹98.00, with the recent high of ₹106.60 indicating limited upside momentum. This price behaviour aligns with the broader technical signals pointing to a cautious outlook in the near term.




Themis Medicare or something better? Our SwitchER feature analyzes this small-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!



  • - SwitchER analysis complete

  • - Superior alternatives found

  • - Multi-parameter evaluation


See Smarter Alternatives →




Implications for Investors


The technical momentum shifts observed in Themis Medicare suggest a period of heightened uncertainty. The mixed signals from MACD, KST, and Dow Theory across weekly and monthly timeframes indicate that while some short-term bullishness may exist, the dominant trend remains under pressure. The absence of clear RSI signals further emphasises the stock’s current indecision in momentum terms.



Investors analysing Themis Medicare should consider the broader market context and the stock’s relative performance against the Sensex. The significant negative returns over recent weeks and months highlight the challenges faced by the company’s shares in regaining investor confidence. The technical indicators collectively point to a cautious stance, with potential for volatility in the near term.



Conclusion


Themis Medicare’s recent technical parameter changes reflect a complex momentum environment. While some weekly indicators show mild bullish tendencies, the prevailing monthly signals and moving averages suggest a bearish undertone. Price action near the lower end of the 52-week range, combined with subdued volume trends, underscores the need for careful analysis before considering new positions. Market participants should monitor these technical signals closely alongside fundamental developments to better understand the stock’s trajectory in the Pharmaceuticals & Biotechnology sector.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News